Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "anaphylaxis" wg kryterium: Temat


Tytuł:
Anaphylaxis during peri-anesthetic period - review of research
Autorzy:
Dąbrowski, S.
Mędrzycka-Dąbrowska, W.
Wojtaszek, M.
Tematy:
Anaphylaxis
Anesthetics
Intraoperative anaphylaxis
Pokaż więcej
Wydawca:
Uniwersytet Medyczny w Białymstoku
Powiązania:
https://bibliotekanauki.pl/articles/1917640.pdf  Link otwiera się w nowym oknie
Opis:
Peri-anesthetic anaphylaxis, mediated by immunologic, nonimmunologic, or undefined mechanisms is a severe and rapid clinical condition that can be lethal. Anesthesiologists use a myriad of drugs during the provision of an anesthetic. Muscle relaxants and latex account for most cases of anaphylaxis during the perioperative period. Symptoms may include all organ systems and present with bronchospasm and cardiovascular collapse in the most severe cases. Management of anaphylaxis includes discontinuation of the presumptive drug (or latex) and anesthetic, aggressive pulmonary and cardiovascular support, and epinephrine.The paper presentsthe pathophysiology, the most common causes and the management of anaphylaxis occurring during anesthesia, based on a review of available literature.
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Is the clinical manifestation of anaphylaxis in children influenced by the trigger of reaction?
Autorzy:
Tomasik, Tomasz
Tarczoń, Izabela
Brzyski, Piotr
Jedynak-Wąsowicz, Urszula
Lis, Grzegorz
Cichocka-Jarosz, Ewa
Opis:
Introduction: The number of anaphylaxis diagnoses in children is rising, being still based on the clinical picture. Aim: To determine whether triggers of anaphylaxis influence its clinical characteristics in children and adolescents. Material and methods: The study group included 114 children (5 months–17 years, mean age: 8.0 ±4.8 years), (66%: boys) with the episode of anaphylaxis up to 1 year back. Medical data were entered to the NORA Registry by means of a validated structured on-line questionnaire. Results: Three most frequent triggers of anaphylaxis were: insect venom (47.4%), food (35.1%), drugs (5.3%), with a predominance of food (egg white, cow’s milk, nuts and peanuts) in the 0–6 years age group, while insect venom (bee predominance) in the 7–17 years age group (p = 0.016). Clinical manifestations differed between food vs. venom allergic reactions and presented as gastro-intestinal (GI) (61.4%) (p = 0.004), respiratory (RS) (93.9%) (p = 0.036), and cardiovascular (CVS) (74.6%) (p = 0.022) symptoms. Among objective symptoms, vomiting was the most common symptom in the 0–2 years age group (47.1%) (p = 0.006), while hypotension in those aged 7 –12 years (40%) (p = 0.010). Severity of symptoms evaluated as Mueller’s grade (IV – 74.5%) and as Ring and Messmer’s grade (III – 65.8%), depended on the trigger (p = 0.028, p = 0.029, respectively). Life-threatening symptoms occurred in 26 children (fall of the blood pressure – 22%, loss of consciousness – 4.4%). Conclusions: The clinical manifestation of anaphylaxis in children is both trigger and age dependent, irrespective of the gender. A typical patient with food anaphylaxis was younger, presenting predominantly GI symptoms, while a typical patient with venom anaphylaxis was older, with mostly cardiovascular symptoms.
Dostawca treści:
Repozytorium Uniwersytetu Jagiellońskiego
Artykuł
Tytuł:
Cow's milk and hen's egg anaphylaxis : a comprehensive data analysis from the European Anaphylaxis Registry
Autorzy:
Nemat, Katja
Scherer Hofmeier, Kathrin
Sabouraud-Leclerc, Dominique
Hompes, Stephanie
Papadopoulos, Nikolaos G.
Ott, Hagen
Dolle-Bierke, Sabine
Spindler, Thomas
Kohli, Alice
Jedynak-Wąsowicz, Urszula
Lange, Lars
Hourihane, Jonathan
Lopes de Oliveira, Lucila
Vogelberg, Christian
Worm, Margitta
Cichocka-Jarosz, Ewa
Opis:
Background: Cow's milk (CM) and hen's egg (HE) are leading triggers of anaphylaxis in early childhood. The aim of this study was to identify clinical phenotypes and therapeutic measures for CM anaphylaxis (CMA) compared to HE anaphylaxis (HEA) in children up to 12 years of age, based on a large pan-European dataset from the European Anaphylaxis Registry. Methods: Data from 2007 to 2020 on clinical phenotypes and treatment from 10 European countries, as well as Brazil, were analysed. The two-step cluster analysis was used to identify the most frequent phenotypes. For each trigger, three clusters were extracted based on sex, age, and existence of symptoms in four vitally important systems. Results: Altogether 284 children with CMA and 200 children with HEA were identified. They were characterised as male (69% vs. 64%), infants (65% vs. 61%), with a most frequent grade III of Ring&Messmer classification (62% vs. 64%), in CMA versus HEA, respectively. Respiratory symptoms occurred more often in CMA (91% vs. 83%, p = 0.010), especially in infants (89% vs. 79%, p = 0.008). Cardiovascular symptoms were less frequent in CMA (30% vs. 44%, p = 0.002), in both infants (33% vs. 46%, p = 0.027), and older children (25% vs. 42%, p = 0.021). The clusters extracted in the CMA group were characterised as: (1) mild dermal infants with severe GI (40%), 2. severe dermal (35%), 3. respiratory (25%). While in HEA group: 1. infants with severe GI and/or reduction of alertness (40%), (2) conjunctival (16%), (3) mild GI without conjunctivitis (44%). The severity of the reaction was independent from the amount of ingested allergen protein, regardless of trigger. The first-line adrenaline application differed between the countries (0%–92%, as well as the reasons for not administering adrenaline, p < 0.001). Conclusions: Despite the similarity of their age, sex, and severity grade, the clinical profiles differed between the CMA and HEA children. Adrenaline was underused, and its administration was country dependent. Further studies are needed to assess to what extent the differences in the clinical profiles are related to matrix and/or absorption effects, and/or the allergen itself.
Dostawca treści:
Repozytorium Uniwersytetu Jagiellońskiego
Artykuł
Tytuł:
Occupational anaphylaxis to food
Autorzy:
Olszewska, Paula
Rymarczyk, Barbara
Gawlik, Radosław
Tematy:
occupational disease
hypersensitivity reaction
occupational anaphylaxis
anaphylaxis to food
immediate allergy
work-related agents
Pokaż więcej
Wydawca:
Instytut Medycyny Pracy im. prof. dra Jerzego Nofera w Łodzi
Powiązania:
https://bibliotekanauki.pl/articles/55992479.pdf  Link otwiera się w nowym oknie
Opis:
Increasing incidence and importance of allergies in everyday life leads to bigger impact on the professional lives of patients. Continuous exposure to various allergens may be a trigger factor of development allergic diseases, even anaphylactic shock. This paper summarizes available knowledge of occupational anaphylaxis to food. This narrative literature review was based on selected, peer‑reviewed research papers, review articles and case reports between 1997–2024. The aim of the review article was to present the growing problem of allergy patients working in the food industry and to draw attention to the danger of anaphylaxis. In addition to the most popular food allergens, such as milk protein, fish, crustaceans and eggs, authors presented less popular, but becoming more important, such as crickets. Due to the increasing popularity of alternative food sources, the significance of food allergies will become more important. It is worth mentioning that occupational anaphylaxis is not only limited to the exposure to the allergen in the workplace. It can happen outside the workplace as a result of repeated exposure, after re-exposure.
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Use of antihistamines for COVID-19 vaccine recipients with risk of anaphylaxis
Autorzy:
Wolff, Monika
Pettersson, Samuel D.
Bidzan, Leszek
Grabowski, Jakub
Brancewicz, Tomasz
Wydawca:
Medical University of Gdańsk
Cytata wydawnicza:
Grabowski J, Wolff M, Pettersson SD, Brancewicz T, Bidzan L. Use of Antihistamines for COVID-19 Vaccine Recipients with Risk of Anaphylaxis. Eur J Transl Clin Med. 2022;5(1):8-11. DOI: 10.31373/ejtcm/138219
Opis:
Allergic reactions to COVID-19 vaccine ranging from mild to severe have been reported in patients with a history of anaphylaxis. Currently, no guidelines are available regarding prevention of allergic reactions in patients with high-risk of anaphylaxis who plan on receiving the SARS-CoV-2 vaccine. In this case-series study, two patients with a history of anaphylaxis had taken antihistaminic drugs prior to their BNT162b2 vaccinations and experienced no major allergic reactions afterwards. The use of antihistamines prior to COVID-19 vaccination may have affected the outcome of the two subjects with history of anaphylaxis history. However, further studies are needed to evaluate efficacy, generalizability and safety of the approach presented in this case-series.
Dostawca treści:
Repozytorium Centrum Otwartej Nauki
Artykuł
Tytuł:
Use of antihistamines for COVID-19 vaccine recipients with risk of anaphylaxis
Autorzy:
Grabowski, Jakub
Wolff, Monika
Pettersson, Samuel D.
Brancewicz, Tomasz
Bidzan, Leszek
Tematy:
vaccine
anaphylaxis
antihistamine
covid-19
Pokaż więcej
Wydawca:
Gdański Uniwersytet Medyczny
Powiązania:
https://bibliotekanauki.pl/articles/2203250.pdf  Link otwiera się w nowym oknie
Opis:
Allergic reactions to COVID-19 vaccine ranging from mild to severe have been reported in patients with a history of anaphylaxis. Currently, no guidelines are available regarding prevention of allergic reactions in patients with high-risk of anaphylaxis who plan on receiving the SARS-CoV-2 vaccine. In this case-series study, two patients with a history of anaphylaxis had taken antihistaminic drugs prior to their BNT162b2 vaccinations and experienced no major allergic reactions afterwards. The use of antihistamines prior to COVID-19 vaccination may have affected the outcome of the two subjects with history of anaphylaxis history. However, further studies are needed to evaluate efficacy, generalizability and safety of the approach presented in this case-series.
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Intervention in anaphylaxis : the experience of one paediatric centre based on NORA reports
Autorzy:
Tomasik, Tomasz
Brzyski, Piotr
Jedynak-Wąsowicz, Urszula
Lis, Grzegorz
Cichocka-Jarosz, Ewa
Tarczon, Izabela
Opis:
Introduction: Intramuscular adrenaline administration is the primary intervention in anaphylaxis. Aim: To analyse the data on intervention in children admitted due to anaphylaxis to the tertiary paediatric centre and compare them to the data from the Network for Online-Registration of Anaphylaxis. Material and methods: A validated structured on-line questionnaire was used to collect data concerning the first and second-line intervention in anaphylaxis. The study was conducted in cooperation with the European Anaphylaxis Registry. Results: The study group comprised 114 children (76 boys, 66.87%) aged 5 months–17 years with the predominance of moderate-to-severe anaphylaxis (grade III in Ring and Messmer’s, and grade IV in Mueller’s scale). In 103 (90.4%) children the first line of medical intervention was provided by medical staff. In the first-line intervention 39 (34.8%) children were given adrenaline. Five (4.4%) children were given the second dose of adrenaline and were admitted to the intensive care unit. In the second-line intervention adrenaline was given to 12 (15.6%) children. In one third it was at least the second reaction to the same trigger. Children treated with adrenaline were older (9.3 ±4.8 years), in comparison to those not treated (7.3 ±4.6 years, p = 0.034). Directly after the episode of anaphylaxis the children got the prescription for the adrenaline autoinjector in 35.1%, emergency training in 7.9%, and counselling on the avoidance of the anaphylaxis trigger in 30.7%. Grade III R&M reaction increased 3-fold the odds of AAI prescription (95% CI: 1.08–8.15). Conclusions: There is a strong need to continue education on proper management of anaphylaxis in children.
Dostawca treści:
Repozytorium Uniwersytetu Jagiellońskiego
Artykuł
Tytuł:
The incidence of lidocaine allergy in dentists: an evaluation of 100 general dental practitioners
Autorzy:
Janas-Naze, Anna
Osica, Piotr
Tematy:
allergy
dentists
anaphylaxis
lidocaine
hypersensitivity
local anaesthetics
Pokaż więcej
Wydawca:
Instytut Medycyny Pracy im. prof. dra Jerzego Nofera w Łodzi
Powiązania:
https://bibliotekanauki.pl/articles/2161981.pdf  Link otwiera się w nowym oknie
Opis:
Objectives Local anesthetics are some of the most common drugs used in dentistry and about 6 million people daily around the world are subjected to their effect in procedures performed by a similar number of dentists who, in turn, are usually not aware of the fact of being allergic to this group of medications. Assuming that dentists are also patients, and that in their daily practice the contact with the allergen is very frequent, it is essential to assess the incidence of allergy to lidocaine in general dental practitioners. Material and Methods The authors evaluated a group of 100 general dental practitioners in whom adverse reactions similar to anaphylaxis occurred after local anesthesia. The study included individuals who, in their thorough medical history, had experienced episodes of such reactions regarding the skin, airways, gastrointestinal tract and other areas. Results The relations between type I hypersensitivity and certain symptoms, time from exposure to their appearance, as well as time from the last episode were investigated. Allergy to lidocaine was detected in 17 subjects – type I hypersensitivity was diagnosed in 13 cases (skin prick test – 7; intradermic test – 6) and 4 subjects had IgE-independent allergy (patch test). In the group where type I hypersensitivity was detected, urticaria, angioedema and rhinitis were indicated as inclusion criteria more often than among other subjects. According to the results, the occurrence of angioedema increased the risk of detection of type I hypersensitivity 68.8 times, and 1 year longer period from the last episode decreased this risk by circa 55%. Conclusions The most important, from the clinical practice point of view, was to show the relation between the medical history indicating the anaphylactic nature of the lidocaine intolerance, and an allergy confirmed by skin tests. Int J Occup Med Environ Health. 2019;32(3):333–9
Dostawca treści:
Biblioteka Nauki
Artykuł

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies